ESR1 and breast carcinoma: The 2012 Lancet Oncology review [48] showed that Clemmesen’s Hook occurred in ER+ breast cancers, while the SEER publication [49] pin-pointed Clemmesen’s Hook as affecting ER+ PR+ breast cancers (Figure 2c).